Literature DB >> 17317320

Analyses of immunosenescent markers in patients with autoimmune disease.

Marielle Thewissen1, Veerle Somers, Koen Venken, Loes Linsen, Pieter van Paassen, Piet Geusens, Jan Damoiseaux, Piet Stinissen.   

Abstract

The objective of this study was to evaluate the degree of immunosenescence in patients with autoimmune disease. T cell receptor excision circles (TREC) and the percentage of CD4+CD28null T cells were studied as markers of immunosenescence in 175 patients with chronic autoimmune arthritis, other connective tissue autoimmune diseases, multiple sclerosis and 60 healthy controls. In both the rheumatoid arthritis (RA) and multiple sclerosis patient group, TREC numbers were age-inappropriately declined which points to an accelerated thymic output. Furthermore, enhanced percentages of CD4+CD28null T cells could be detected in a significant proportion of patients included in this study. These immunosenescent phenomena seemed to be present already early in the disease process. High percentages of CD4+CD28null T cells were associated with the presence of RA linked HLA DR4 alleles and with plasma reactivity to cytomegalovirus. Further analysis of CD4+CD28null T cells provided indications for a restricted T cell receptor (TCR) BV gene expression and cytoplasmic stores of various cytotoxic molecules. This study indicates that the immune system of patients with autoimmune diseases shows signs of an accelerated aging. Both genetic factors, such as HLA DR4, and environmental factors, like CMV infection, might speed up this immunosenescence and contribute in this way to disease pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17317320     DOI: 10.1016/j.clim.2007.01.005

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  43 in total

Review 1.  [Immunosenescence. Current status and molecular mechanisms].

Authors:  T Peters
Journal:  Hautarzt       Date:  2011-08       Impact factor: 0.751

2.  Rheumatoid arthritis in the Women's Health Initiative: methods and baseline evaluation.

Authors:  Lewis H Kuller; Rachel H Mackey; Brian T Walitt; Kevin D Deane; V Michael Holers; William H Robinson; Jeremy Sokolove; Yuefang Chang; Larry W Moreland
Journal:  Am J Epidemiol       Date:  2014-02-24       Impact factor: 4.897

Review 3.  Immunosenescence and rheumatoid arthritis: does telomere shortening predict impending disease?

Authors:  Karen H Costenbader; Jennifer Prescott; Robert Y Zee; Immaculata De Vivo
Journal:  Autoimmun Rev       Date:  2011-05-07       Impact factor: 9.754

Review 4.  Synthetic DNA approach to cytomegalovirus vaccine/immune therapy.

Authors:  Stephan J Wu; Daniel O Villarreal; Devon J Shedlock; David B Weiner
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

Review 5.  Systemic sclerosis-associated fibrosis: an accelerated aging phenotype?

Authors:  Tracy R Luckhardt; Victor J Thannickal
Journal:  Curr Opin Rheumatol       Date:  2015-11       Impact factor: 5.006

Review 6.  Immune aging and autoimmunity.

Authors:  Jörg J Goronzy; Cornelia M Weyand
Journal:  Cell Mol Life Sci       Date:  2012-04-01       Impact factor: 9.261

7.  T-cell compartment in synovial fluid of pediatric patients with JIA correlates with disease phenotype.

Authors:  Ninette Amariglio; Adi Klein; Lana Dagan; Atar Lev; Shai Padeh; Gideon Rechavi; Yackov Berkun; Raz Somech
Journal:  J Clin Immunol       Date:  2011-09-08       Impact factor: 8.317

Review 8.  The life (and death) of CD4+ CD28(null) T cells in inflammatory diseases.

Authors:  Ingrid E Dumitriu
Journal:  Immunology       Date:  2015-09-07       Impact factor: 7.397

9.  High levels of lung resident CD4+CD28null cells in COPD: implications of autoimmunity.

Authors:  K Hoetzenecker; A Mitterbauer; E Guenova; T Schweiger; P Altmann; M Zimmermann; H Hofbauer; L Beer; W Klepetko; H J Ankersmit
Journal:  Wien Klin Wochenschr       Date:  2013-03-27       Impact factor: 1.704

10.  Compromised CD4+ CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level.

Authors:  Koen Venken; Niels Hellings; Marielle Thewissen; Veerle Somers; Karen Hensen; Jean-Luc Rummens; Robert Medaer; Raymond Hupperts; Piet Stinissen
Journal:  Immunology       Date:  2007-09-25       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.